Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinoid targets for apoptosis induction.

Magnus Pfahl1, Francisco Javier Piedrafita

  • 1Incyte San Diego, Inc, 10835 Altman Row, San Diego, CA 92121, USA. pfahl@incyte.com

Oncogene
|December 10, 2003
PubMed
Summary

New synthetic retinoids trigger cancer cell death (apoptosis) by targeting protein kinases and phosphatases, independent of nuclear retinoid receptors. This novel mechanism offers potential for developing new anticancer drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of apoptosis by the synthetic retinoid MX3350-1 through extrinsic and intrinsic pathways in head and neck squamous carcinoma cells.

Oncogene·2005
Same author

Inhibition of IkappaB kinase by a new class of retinoid-related anticancer agents that induce apoptosis.

Molecular and cellular biology·2003
See all related articles

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Pharmacology

Background:

  • Retinoids are known for their diverse biological effects, including anticancer properties.
  • Traditional retinoid action involves nuclear retinoid receptors, regulating gene expression.
  • A novel class of synthetic retinoid-related molecules exhibits anticancer activity through a different mechanism.

Purpose of the Study:

  • To elucidate the novel mechanism of action for synthetic retinoid-related molecules inducing apoptosis in cancer cells.
  • To identify the specific protein targets and signaling pathways involved in retinoid-induced apoptosis.
  • To explore the potential of these compounds as novel anticancer agents.

Main Methods:

  • Investigated the effects of synthetic retinoid-related molecules on cancer cell apoptosis.
  • Analyzed the involvement of protein kinases and phosphatases in retinoid signaling.
  • Examined the role of mitochondrial pathways, including cytochrome c release and caspase activation.
  • Utilized specific retinoid agonists (e.g., CD437) and antagonists (e.g., MX781) to probe signaling pathways.

Main Results:

  • Synthetic retinoids induce apoptosis independently of nuclear retinoid receptors.
  • These molecules target protein kinases and phosphatases, modulating critical signal transduction pathways.
  • Retinoid agonists (CD437) activate stress kinases by inhibiting MKP-1.
  • Retinoid antagonists (MX781) inhibit the survival kinase IKK.
  • Signaling converges at the mitochondria, leading to cytochrome c release and caspase activation.

Conclusions:

  • A novel, receptor-independent mechanism of retinoid action induces cancer cell apoptosis.
  • Targeting protein kinases and phosphatases represents a new therapeutic strategy for cancer.
  • Understanding these pathways allows for the optimization of retinoid-based anticancer compounds for clinical application.

Related Experiment Videos